Immunology

Papers
(The TQCC of Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
New‐onset autoimmune phenomena post‐COVID‐19 vaccination285
Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China210
T‐cell responses and therapies against SARS‐CoV‐2 infection154
Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease93
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world76
Haemocyte‐mediated immunity in insects: Cells, processes and associated components in the fight against pathogens and parasites72
Cytokine‐regulated Th17 plasticity in human health and diseases67
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection66
The NLRP6 inflammasome59
New developments in our understanding of ankylosing spondylitis pathogenesis58
Interleukin‐17 and ischaemic stroke48
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function47
The role of Bruton's tyrosine kinase in the immune system and disease46
Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset40
NLRP7: From inflammasome regulation to human disease40
NK‐cell exhaustion, B‐cell exhaustion and T‐cell exhaustion—the differences and similarities40
Why do intestinal epithelial cells express MHC class II?39
Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine‐mediated leukocyte recruitment36
Endocannabinoids in immune regulation and immunopathologies36
Inhibition of the NLRP3 inflammasome by HSP90 inhibitors36
Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment35
Candida albicans and candidalysin in inflammatory disorders and cancer35
Targeting immunometabolism in host defence against Mycobacterium tuberculosis34
Neutrophil and remnant clearance in immunity and inflammation34
Human FOXP3 and tumour microenvironment33
Tissue regulatory T cells32
Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages32
Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data31
Single‐cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer30
NLR in eXile: Emerging roles of NLRX1 in immunity and human disease30
Crosstalk between B cells and neutrophils in rheumatoid arthritis29
Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva29
Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS‐CoV‐229
Macrophage reprogramming for therapy29
Emerging roles of extracellular vesicles in COVID‐19, a double‐edged sword?28
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial28
Neuromedin U: potential roles in immunity and inflammation28
B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy28
Neutrophil–T cell crosstalk in inflammatory bowel disease27
The battle for iron in enteric infections27
Retinal microglia: Functions and diseases26
Crosstalk between circadian rhythms and the microbiota26
Oral microbiome interactions with gingival gene expression patterns for apoptosis, autophagy and hypoxia pathways in progressing periodontitis25
MHC class I transactivator NLRC5 in host immunity, cancer and beyond25
Targeting metabolism to reverse T‐cell exhaustion in chronic viral infections24
Neutrophils in pregnancy: New insights into innate and adaptive immune regulation23
Siglec‐5 is an inhibitory immune checkpoint molecule for human T cells23
IL‐36 cytokines and gut immunity23
Enigmatic inflammasomes23
Differential immune responses of immunoglobulin Z subclass members in antibacterial immunity in a zebrafish model22
The role of B cells in the immunopathogenesis of multiple sclerosis22
Circles of Life: linking metabolic and epigenetic cycles to immunity22
Double‐negative T cells: Setting the stage for disease control or progression22
Cytoplasmic‐translocated Ku70 senses intracellular DNA and mediates interferon‐lambda1 induction21
Hypoxia‐inducible factor‐1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases21
Regulation of CTLA‐4 recycling by LRBA and Rab1120
Vaccines, adjuvants and key factors for mucosal immune response20
Our evolving view of neutrophils in defining the pathology of chronic lung disease20
IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells20
Landscape of variable domain of heavy‐chain‐only antibody repertoire from alpaca20
Cellular landscape of tumour microenvironment in prostate cancer20
Unknown/enigmatic functions of extracellular ASC20
The immune response to COVID‐19: Does sex matter?20
Functional differentiation and regulation of follicular T helper cells in inflammation and autoimmunity20
The role of hydrogen sulphide signalling in macrophage activation19
Annexin‐A1: The culprit or the solution?19
Depletion of langerin+ cells enhances cutaneous wound healing19
HIV infection suppresses TLR3 activation‐mediated antiviral immunity in microglia and macrophages19
Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers18
HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐1918
Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17‐like cells in multiple sclerosis patients with major depression18
Cell death as part of innate immunity: Cause or consequence?18
ATP/IL‐33‐triggered hyperactivation of mast cells results in an amplified production of pro‐inflammatory cytokines and eicosanoids17
LincRNA‐EPS alleviates severe acute pancreatitis by suppressing HMGB1‐triggered inflammation in pancreatic macrophages17
The turning away of serum amyloid A biological activities and receptor usage17
Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy17
CD8+ T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy17
Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models17
The roles of interleukin‐1 receptor accessory protein in certain inflammatory conditions17
Interleukin‐33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response17
Metabolic plasticity and regulation of T cell exhaustion16
MicroRNA‐590‐3p inhibits T helper 17 cells and ameliorates inflammation in lupus mice16
Schistosome and intestinal helminth modulation of macrophage immunometabolism16
Update on the current knowledge of lymphatic drainage system and its emerging roles in glioma management16
The relationship between peripheral immune response and disease severity in SARS‐CoV‐2‐infected subjects: A cross‐sectional study16
Advances in the study of CD47‐based bispecific antibody in cancer immunotherapy15
Recent developments in immunotherapy of cancers caused by human papillomaviruses15
Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin‐derived mutant epitopes15
Stromal–immune cell crosstalk fundamentally alters the lung microenvironment following tissue insult15
Unboxing dendritic cells: Tales of multi‐faceted biology and function15
NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA‐E15
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐1915
The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic14
Induction of the apoptosis, degranulation and IL‐13 production of human basophils by butyrate and propionate via suppression of histone deacetylation14
Ectopic endometriotic stromal cells‐derived lactate induces M2 macrophage polarization via Mettl3/Trib1/ERK/STAT3 signalling pathway in endometriosis14
HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses14
Immune response during hantavirus diseases: implications for immunotherapies and vaccine design14
Implications of cellular metabolism for immune cell migration14
The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity14
Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients13
The role of high‐density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity13
The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia13
Preselection TCR repertoire predicts CD4+ and CD8+ T‐cell differentiation state13
Developing an immune‐related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer13
Age‐related changes in ocular mucosal tolerance: Lessons learned from gut and respiratory tract immunity13
Epigenetics: An opportunity to shape innate and adaptive immune responses13
PTBP1 is necessary for dendritic cells to regulate T‐cell homeostasis and antitumour immunity13
NLRP9 in innate immunity and inflammation13
Immunometabolism shapes B cell fate and functions13
Nanoparticle‐mediated targeting of autoantigen peptide to cross‐presenting liver sinusoidal endothelial cells protects from CD8 T‐cell‐driven autoimmune cholangitis13
PAQR11 modulates monocyte‐to‐macrophage differentiation and pathogenesis of rheumatoid arthritis13
Effector immune cells in chronic lung allograft dysfunction: A systematic review13
Ubiquitin E3 ligase MID1 inhibits the innate immune response by ubiquitinating IRF313
Tacrolimus (FK506) treatment protects allergen‐, IL‐5‐ and IL‐13‐induced mucosal eosinophilia12
Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases12
Thyrotrophin and thyroxine support immune homeostasis in humans12
Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture12
Complement activation by human IgG antibodies to galactose‐α‐1,3‐galactose12
Inducible ablation of CD11c+ cells to determine their role in skin wound repair12
Heterogeneous cancer‐associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer12
MicroRNA‐7 negatively regulates Toll‐like receptor 4 signaling pathway through FAM177A12
Role of CD14 in human disease12
TIM3/CEACAM1 pathway involves in myeloid‐derived suppressor cells induced CD8+ T cells exhaustion and bone marrow inflammatory microenvironment in myelodysp11
Anti‐tumour potential of PD‐L1/PD‐1 post‐translational modifications11
Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity11
IL‐20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation11
NLR family pyrin domain containing 3 (NLRP3) and caspase 1 (CASP1) modulation by intracellular Cl concentration11
The paradoxical role of radiation‐induced cGAS–STING signalling network in tumour immunity11
The role of O‐GlcNAcylation in immunity against infections11
Glycans as shapers of tumour microenvironment: A sweet driver of T‐cell‐mediated anti‐tumour immune response11
Improved prediction of HLA antigen presentation hotspots: Applications for immunogenicity risk assessment of therapeutic proteins10
Suppression of airway allergic eosinophilia by Hp‐TGM, a helminth mimic of TGF‐β10
Multi‐responsive mesoporous polydopamine composite nanorods cooperate with nano‐enzyme and photosensitiser for intensive immunotherapy of bladder cancer10
Macrophage metabolism in the intestine is compartment specific and regulated by the microbiota10
Neutrophils in secondary lymphoid organs10
The role of HMGB1 in COVID‐19‐induced cytokine storm and its potential therapeutic targets: A review10
Human CD36hi monocytes induce Foxp3+ CD25+ T cells with regulatory functions from CD4 and CD8 subsets10
Interdependencies between Toll‐like receptors in Leishmania infection10
Preclinical models for studying immune responses to traumatic injury10
Elucidating host–microbe interactions in vivo by studying population dynamics using neutral genetic tags10
Diabetes and susceptibility to infections: Implication for COVID‐1910
Characterizing the original anti‐C5 function‐blocking antibody, BB5.1, for species specificity, mode of action and interactions with C510
Transcriptomic profiling of cardiac tissues from SARS‐CoV‐2 patients identifies DNA damage10
Targeting glycolysis in Th2 cells by pterostilbene attenuates clinical severities in an asthmatic mouse model and IL‐4 production in peripheral blood from asthmatic patients9
Immunomodulatory functions of TRPM7 and its implications in autoimmune diseases9
The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2+γδ T cells in the modulation9
Development of novel reagents to chicken FLT3, XCR1 and CSF2R for the identification and characterization of avian conventional dendritic cells9
The kinetics of IgG subclasses and contributions to neutralizing activity against SARS‐CoV‐2 wild‐type strain and variants in healthy adults immunized with inactivated vaccine9
CD11c participates in triggering acute graft‐versus‐host disease during bone marrow transplantation9
p38 MAPK signaling mediates retinoic acid‐induced CD103 expression in human dendritic cells9
A comprehensive review of IL‐26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections9
Metabolic manipulation of the tumour immune microenvironment9
Metabolomic and lipidomic signatures associated with activation of human cDC1 (BDCA3+/CD141+) dendritic cells8
The UK Veterinary Immunological Toolbox Website: promoting vaccine research by facilitating communication and removing reagent barriers8
Cell origin and niche availability dictate the capacity of peritoneal macrophages to colonize the cavity and omentum8
Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology8
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka8
Biological functions of IL‐17‐producing cells in mycoplasma respiratory infection8
Neutralizing interferon‐α blocks inflammation‐mediated vascular injury via PI3K and AMPK in systemic lupus erythematosus8
The human natural anti‐αGal antibody targets common pathogens by broad‐spectrum polyreactivity8
Gasdermin D‐independent release of interleukin‐1β by living macrophages in response to mycoplasmal lipoproteins and lipopeptides8
TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+ T cells8
T‐cell exhaustion in CAR‐T‐cell therapy and strategies to overcome it8
Mononuclear phagocyte regulation by the transcription factor Blimp‐1 in health and disease8
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka8
Quantifying immunoregulation by autoantigen‐specific T‐regulatory type 1 cells in mice with simultaneous hepatic and extra‐hepatic autoimmune disorders8
Interferon‐α promotes MHC I antigen presentation of islet β cells through STAT1‐IRF7 pathway in type 1 diabetes8
Heat inactivated mycobacteria, alpha‐Gal and zebrafish: Insights gained from experiences with two promising trained immunity inductors and a validated animal model8
0.040098905563354